Konjac Glucomannan: A functional food additive for preventing metabolic syndrome (original) (raw)
- View PDF
Under a Creative Commons license
open access
Highlight
- •
KGM can anti-type 2 diabetes, anti-obesity and lower blood pressure and lipids. - •
The hydration capacity and increased viscosity of KGM makes it able to increase satiety, slow glycemic response and restrict lipid absorption. - •
KGM prevents Metabolic Syndrome by regulating the gut microbiota. - •
KGM can be used as a substrate for intestinal microbial fermentation to produce beneficial fermentation products.
Abstract
Metabolic syndrome (MS), which involves visceral obesity, hyperglycemia, hypertension, and dyslipidemia, has become a global health challenge. Preventive measures include lifestyle changes, dietary treatments, etc. Konjac has been widely used as a culinary ingredient and traditional Chinese medicine in Asian countries for thousands of years. The main component of the konjac tuber is konjac glucomannan (KGM), a kind of hydrocolloid dietary fiber. Many health problems and diseases are affected by the gut microbiota, which may provide an alternative for preventing disease. In this review, we describe the prevention and treatment of MS using KGM, with a focus on its impact in relation to the regulation of gut microbes. Developing a comprehensive understanding of the role played by KGM via the gut microbiota will help us to determine the underlying mechanisms of KGM for the treatment of diseases associated with the gut microbiota.
Graphical abstract
Keywords
Metabolic syndrome
Konjac glucomannan
Gut microbiota
Abbreviations
BCAAs
branched-chain amino acids
Cpt-1
Carnitine palmitoyl transferase-1
DKD
diabetic kidney disease
eWAT
epididymal white adipose tissue
GBD
global burden of disease
GLP-1
glucagon-like peptide-1
GPIHBP1
GPI-anchored protein HDL binding protein 1
HDL-C
high-density lipoprotein cholesterol
HFD-STZ
high-fat-diet Streptozotocin
Hsl
hormone-sensitive lipase
KEGG
Kyoto Encyclopedia of Genes and Genomes
LDL-C
low-density lipoprotein cholesterol
OGTT
oral glucose tolerance test
PKGM
pulverized konjac glucomannan
Pparg
proliferator-activated receptor gamma
SCFAs
short-chain fatty acids
Srebp
sterol regulatory element-binding protein
T2DM
type 2 diabetes mellitus
Data availability
No data was used for the research described in the article.
Cited by (0)
© 2024 The Authors. Published by Elsevier Ltd.